A review of plants used in the treatment of liver disease: Part two

Alternative Medicine Review

Volumn 4, Issue 3, 1999, Pages 178-189

  Luper, Scott ^a  

^a SW College of Naturopathic Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; KUTKIN; PLANT EXTRACT; SILYBUM MARIANUM EXTRACT;

CURCUMA LONGA; DRUG EFFECT; DRUG USE; GLYCYRRHIZA; HUMAN; LIVER DISEASE; MEDICAL RESEARCH; REVIEW;

EID: 0033024541     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Leung A. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. John Wiley & Sons, New York, NY, 1980:313-314.
2. Ammon HPT, Wahl MA. Pharmacology of Curcuma longa. Planta Medico 1991;57:1-7.
3. Wahlstrom B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol 1978;43:86-92.
4. Ravindranath V, Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Toxicol 1980;16:259-265.
5. Shoba G, Joy D, Joseph T, et al. Influence of pipeline on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998;64:353-356.
6. Shankar TNB, Shantha NV, Ramesh NP, et al. Toxicity studies on turmeric (Curcuma longa): Acute toxicity studies in rats, guinea pigs, and monkeys. Indian J Exp Biol 1980;18:86-92.
7. Xiang ZX, He XQ, Zhou GF, et al. Protective effects of an ethanolic extract and essential oil of Curcuma kwangsinensis S. against experimental liver lesions in mice. Chung Kuo Chung Yao Tsa Chih 1989;14:303-305, 320. [Article in Chinese]
8. Deshpande UR, Gadre SG, Raste AS, et al. Protective effect of turmeric (Curcuma longa L.) extract on carbon tetrachloride-induced liver damage in rats. Indian J Exp Biol 1998;36:573-577.
9. Kiso Y, Suzuki Y, Watanabe N, et al. Antihepatoxic principles of Curcuma longa rhizomes. Planta Med 1983;49:185-187.
10. Piper JT, Singhal SS, Salameh MS, et al. Mechanisms of anticarcinogenic properties of curcumin: the effect of curcumin on glutathione linked detoxification enzymes in rat liver. Int J Biochem Cell Biol 1998;30:445-456.
11. Donatus IA, Sardjoko, Vermeulen NP. Cytotoxic and cytoprotective activities of curcumin. Effects on paracetamol-induced cytotoxicity, lipid peroxidation and glutathione depletion in rat hepatocytes. Biochem Pharmacol 1990;39:1869-1875.
12. Choiu JW, Wei HC, Chunk-Kuo. Preliminary study on the anti-oxidative components of some species grown in Taiwan. Nung Yeh Hua Hsuch Hui Chih 1983;21:97-103.
13. Moken Y, Xianping D, Yaoshu T. Studies on the chemical constituents of common turmeric (Curcuma longa). Zhongcoayoa 1984;15:197-198.
14. Shalini VK, Srinivas L. Lipid peroxide induced DNA damage: Protection by turmeric (Curcuma longa). Mol Cell Biochem 1987;777:3-10.
15. Srinivas L, Shalini VK. DNA damage by smoke: Protection by turmeric and other inhibitors of ROS. Free Radical Biol Med 1991;11:277-283.
16. Selvam R, Subramanian L, Gayathri R, et al. The anti-oxidant activity of turmeric (Curcuma longa). J Ethnopharmacol 1995;47:59-67.
17. Reddy AC, Lokesh BR. Effect of dietary turmeric (Curcuma longa) on iron-induced lipid peroxidation in the rat liver. Food Chem Toxicol 1994;32:279-283.
18. Soni KB, Lahiri M, Chackradeo P, et al. Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity. Cancer Lett 1997;115:129-133.
19. Soni KB, Rajan A, Kuttan R. Reversal of aflatoxin induced liver damage by turmeric and curcumin. Cancer Lett 1992;66:115-121.
20. Susan M, Rao MN. Induction of glutathione S-transferase activity by curcumin in mice. Arzneimittelforschung 1992;42:962-964.
21. Chandra D, Gupta S. Anti-inflammatory and antiarthritic activity of volatile oil of Curcuma longa (Haldi). Ind J Med Res 1972;60:138-142.
22. Arora R, Basu N, Kapoor V, et al. Anti-inflammatory studies on Curcuma longa (turmeric). Ind J Med Res 1971;59:1289-1295.
23. Mukhopadhyay A, Basu N, Ghatak N, et al. Antiinflammatory and irritant activities of curcumin analogues in rats. Agents Actions 1982;12:508-515.
24. Shimizu S, Jareonkitmongkol S, Kawashima H, et al. Inhibitory effect of curcumin on fatty acid desaturation in Mortierella alpina 1S-4 and rat liver microsomes. Lipids 1992;27:509-512.
25. Ramprasad C, Sirsi M. Curcuma longa and bile secretion - Quantitative changes in the bile constituents induced by sodium curcuminate. J Sci Indust Res 1957;16C:108-110.
26. Van het Hof KH, Kivits GA, Weststrate JA, et al. Bioavailability of catechins from tea: the effect of milk. Eur J Clin Nutr 1998;52:356-359.
27. Ody P. The Complete Medicinal Herbal. Dorling Kindersley Ltd, London, 1993:44.
28. Tyler VE, Brady LR, Robbers JE. Pharmacognosy, 9th edition. Lea and Febiger, Philadelphia, PA 1988:247-248.
29. Sano M, Takahashi Y, Yoshino K, et al. Effect of tea (Camellia sinensis L.) on lipid peroxidation in rat liver and kidney: a comparison of green and black tea feeding. Biol Pharm Bull 1995;18:1006-1008.
30. Obermeier MT, White RE, Yang CS. Effects of bioflavonoids on hepatic P450 activities. Xenobiotica 1995;25:575-584.
31. Miyagawa C, Wu C, Kennedy DO, et al. Protective effect of green tea extract and tea polyphenols against the cytotoxicity of 1,4-naphthoquinone in isolated rat hepatocytes. Biosci Biotechnol Biochem 1997;61:1901-1905.
32. Cao J, Xu Y, Chen J, et al. Chemopreventive effects of green and black tea on pulmonary and hepatic carcinogenesis. Fundam Appl Toxicol 1996;29:244-250.
33. Yang CS, Chen L, Lee MJ, et al. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev 1998;7:351-354.
34. Sai K, Kai S, Umemura T, et al. Protective effects of green tea on hepatotoxicity, oxidative DNA damage and cell proliferation in the rat liver induced by repeated oral administration of 2-nitropropane. Food Chem Toxicol 1998;36:1043-1051.
35. Kushnerova NF, Fomenko SE, Polozhentseva MI, et al. Effect of natural complexes of biologically active substances on liver regeneration in alcohol poisoning. Vopr Med Khim 1995;41:20-23. [Article in Russian]
36. Sugiyama K, He P, Wada S, et al. Green tea suppresses D-galactosamine-induced liver injury in rats. Biosci Biotechnol Biochem 1998;62:609-611.
37. Hasegawa R, Chujo T, Sai-Kato K, et al. Preventive effects of green tea against liver oxidative DNA damage and hepatotoxicity in rats treated with 2-nitropropane. Food Chem Toxicol 1995;33:961-970.
38. Khan SG, Katiyar SK, Agarwal R, Mukhtar H. Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention. Cancer Res 1992;52:4050-4052.
39. Wu Y. Scavenging action of green tea extracts on singlet oxygen and preventive effect on lipid peroxidation. Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao 1993;15:354-359. [Article in Chinese]
40. Bu-Abbas A, Clifford MN, Ioannides C, et al. Stimulation of rat hepatic UDP-glucuronosyl transferase activity following treatment with green tea. Food Chem Toxicol 1995;33:27-30.
41. Sohn OS, Surace A, Fiala ES. Effects of green and black tea on hepatic xenobiotic metabolizing systems in the male F344 rat. Xenobiotica 1994;24:119-127.
42. Rauch G. The immunoenhancing effect of cianidanol (C) on macrophages and on the T-cell system. Methods Find Exp Clin Pharmacol 1986;8:147-150.
43. Suzuki H, Yamamoto S, Hirayama C, et al. Cianidanol therapy for HBe-antigen-positive chronic hepatitis: a multicentre, double-blind study. Liver 1986;6:35-44.
44. Kanai K, Morioka S, Nakajima T, et al. Treatment of chronic hepatitis B with recombinant leukocyte interferon and cyanidanol. Gastroenterol Jpn 1988;23:44-48.
45. Stuhlinger W, Berek K, Grosswang F, et al. Several years observation of a Catergen (cyanidanol-3) induced immunohemolysis. Schweiz Med Wochenschr 1990;120:345-348. [Article in German]
46. Neftel K, Diem P, Gerber H, et al. Hemolytic autoimmune anemia caused by (+)-cyanidanol-3. Schweiz Med Wochenschr 1980;110:380-382. [Article in German]
47. Neftel K, Fontana A, Guggenheim M, et al. Autoimmune hemolysis after Catergen ([+]-cyanidanol-3). Schweiz Med Wochenschr 1987;117:1824-1827. [Article in German]
48. Hayashi M, Yamazoe H, Yamaguchi Y, Kunitomo M. Effects of green tea extract on galactosamine-induced hepatic injury in rats. Nippon Yakurigaku Zasshi 1992;100:391-399. [Article in Japanese]
49. Matsumoto N, Kohri T, Okushio K, et al. Inhibitory effects of tea catechins, black tea extract and oolong tea extract on hepatocarcinogenesis in rats. Jpn J Cancer Res 1996;87:1034-1038.
50. Hirose M, Hasegawa R, Kimura J, et al. Inhibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[ 1,2-a:3′,2′-d]imidazole (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx). Carcinogenesis 1995;16:3049-3055.
51. Hirose M, Hoshiya T, Akagi K, et al. Effects of green tea catechins in a rat multi-organ carcinogenesis model. Carcinogenesis 1993;14:1549-1553.
52. Ody P. The Complete Medicinal Herbal. Dorling Kindersley Ltd, London; 1993:65.
53. th edition. Lea and Febiger, Philadelphia, PA; 1988:68-69.
54. Leung A. Encyclopedia of Common Natural Ingredients Used in Food drugs and Cosmetics. John Wiley and Sons, New York, NY, 1980:220-223.
55. th edition. Merck & Co, Rahway, NJ 1983:4347.
56. Cantelli-Forti G, Raggi MA, Bugamelli F, et al. Toxicological assessment of liquorice: biliary excretion in rats. Pharmacol Res 1997;35:463-470.
57. Wang Z, Nishioka M, Kurosaki Y, et al. Gastrointestinal absorption characteristics of glycyrrhizin from Glycyrrhiza extract. Biol Pharm Bull 1995;18:1238-1241.
58. Takeda R, Morimoto S, Uchida K, et al. Prolonged pseudoaldosteronism induced by glycyrrhizin. Endocrinol Japan 1979;26:541-547.
59. Epstein MrEspiner E, Donald R, et al. Effects of eating liquorice on the renin-angiotensin aldosterone axis in normal subjects. Br Med J 1977;1:488-490.
60. Tamura Y, Nishikawa T, Yamada K. Effects of glycyrrhetinic acid and its derivatives on delta-4-5-alpha and beta-reductase in the rat liver. Arzneim Forsch 1979;29:647-649.
61. Tomita T, Sato T, Kazuo S, et al. Effects of lead and arsenic on the formation of 5-beta-H steroids. Toxicol Letters 1979;3:291-297.
62. Armanini D, Karbowiak I, Funder J. Affinity of liquorice derivative for mineralcorticoid and glucocorticoid receptors. Clin Endocrinol 1983;19:609-612.
63. Murray M, Pizzorno J. A Textbook of Natural Medicine, Bastyr Publishing, Seattle, WA, 1992 V:glycyr-3.
64. Wang GS, Han ZW. The protective action of Glycyrrhiza flavonoids against carbon tetrachloride hepatotoxicity in mice. Yao Hsueh Hsueh Pao 1993;28:572-576. [Article in Chinese]
65. Kiso Y, Tonkin M, Hikino H, et al. Mechanism of antihepatotoxic activity of glycyrhhizin, I: Effect on free radical generation and lipid peroxidation. Planta Medica 1984;50:298-302.
66. Haraguchi H, Ishikawa H, Mizutani K, et al. Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorg Med Chem 1998;6:339-347.
67. Moon A, Kim SH. Effect of Glycyrrhiza glabra roots and glycyrrhizin on the glucuronidation in rats. Planta Med 1997;63:115-119.
68. Paolini M, Pozzetti L, Sapone A, et al. Effect of licorice and glycyrrhizin on murine liver CYP-dependent monooxygenases. Life Sci 1998;6:571-582.
69. Galitskii LA, Barnaulov OD.-Zaretskii BV, et al. Effect of phytotherapy on the prevention and elimination of hepatotoxic responses in patients with pulmonary tuberculosis, carriers of hepatitis B virus markers. Probl Tuberk 1997;4:35-38. [Article in Russian]
70. Crance JM, Biziagos E, Passagot J, et al. Inhibition of Hepatitis A replication in vitro by antiviral compounds. J Med Virol 1990;31:155-160.
71. Baba M, Shigeta S. Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro. Antiviral Res 1987;7:99-107.
72. Ito M, Nakashima H, Baba M, et al. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)]. Antiviral Res 1987;7:127-137.
73. Pompei R, Flore O, Marccialis MA, et al. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature 1979;281:689-690.
74. Pompei R, Pani A, Flore O, et al. Antiviral activity of glycyrrhizic acid. Experientia 1980;36:304.
75. Susuki H, Ohta Y, Takino T, et al. Effects of glycyrrhizin on biochemical test with patient with chronic hepatitis - Double blind trial. Asian Med J 1984;26:423-438.
76. Acharya SK, Dasarathy S, Tandon A, et al. A preliminary open trial on interferon stimulator (SNMC) derived from Glycyrrhiza glabra in the treatment of subacute hepatic failure. Indian J Med Res 1993;98:69-74.
77. Xianshi S, Huiming C, Lizhuang W, et al. Clinical and laboratory observation on the effect of glycyrrhizin in acute and chronic viral hepatitis. J Trad Chin Med 1984;4:127-132.